FBIOX vs. FAGIX
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity Capital & Income Fund (FAGIX).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. FAGIX is managed by Fidelity. It was launched on Nov 1, 1977.
Performance
FBIOX vs. FAGIX - Performance Comparison
Loading graphics...
FBIOX vs. FAGIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | -3.22% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -10.92% | 27.87% |
FAGIX Fidelity Capital & Income Fund | -0.85% | 12.38% | 10.69% | 13.02% | -11.50% | 11.13% | 9.95% | 18.96% | -7.17% | 11.66% |
Returns By Period
In the year-to-date period, FBIOX achieves a -3.22% return, which is significantly lower than FAGIX's -0.85% return. Over the past 10 years, FBIOX has outperformed FAGIX with an annualized return of 9.85%, while FAGIX has yielded a comparatively lower 7.42% annualized return.
FBIOX
- 1D
- 0.08%
- 1M
- -6.89%
- YTD
- -3.22%
- 6M
- 11.54%
- 1Y
- 33.83%
- 3Y*
- 17.53%
- 5Y*
- 3.77%
- 10Y*
- 9.85%
FAGIX
- 1D
- -0.56%
- 1M
- -3.17%
- YTD
- -0.85%
- 6M
- 0.91%
- 1Y
- 12.88%
- 3Y*
- 10.34%
- 5Y*
- 5.79%
- 10Y*
- 7.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. FAGIX - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than FAGIX's 0.67% expense ratio.
Return for Risk
FBIOX vs. FAGIX — Risk / Return Rank
FBIOX
FAGIX
FBIOX vs. FAGIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity Capital & Income Fund (FAGIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBIOX | FAGIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.35 | 1.91 | -0.57 |
Sortino ratioReturn per unit of downside risk | 1.84 | 2.63 | -0.79 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.39 | -0.15 |
Calmar ratioReturn relative to maximum drawdown | 2.10 | 2.79 | -0.69 |
Martin ratioReturn relative to average drawdown | 7.73 | 11.77 | -4.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBIOX | FAGIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.35 | 1.91 | -0.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.90 | -0.75 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.96 | -0.58 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.47 | 0.85 | -0.38 |
Correlation
The correlation between FBIOX and FAGIX is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
FBIOX vs. FAGIX - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 2.55%, less than FAGIX's 4.43% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 2.55% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
FAGIX Fidelity Capital & Income Fund | 4.43% | 4.74% | 5.02% | 5.28% | 10.25% | 6.08% | 4.59% | 5.00% | 5.67% | 5.05% | 4.57% | 4.51% |
Drawdowns
FBIOX vs. FAGIX - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.98%, which is greater than FAGIX's maximum drawdown of -37.97%. Use the drawdown chart below to compare losses from any high point for FBIOX and FAGIX.
Loading graphics...
Drawdown Indicators
| FBIOX | FAGIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.98% | -37.97% | -34.01% |
Max Drawdown (1Y)Largest decline over 1 year | -12.27% | -4.41% | -7.86% |
Max Drawdown (5Y)Largest decline over 5 years | -44.87% | -15.42% | -29.45% |
Max Drawdown (10Y)Largest decline over 10 years | -48.66% | -28.45% | -20.21% |
Current DrawdownCurrent decline from peak | -7.32% | -3.49% | -3.83% |
Average DrawdownAverage peak-to-trough decline | -23.72% | -7.01% | -16.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.05% | 1.05% | +3.00% |
Volatility
FBIOX vs. FAGIX - Volatility Comparison
Fidelity Select Biotechnology Portfolio (FBIOX) has a higher volatility of 7.30% compared to Fidelity Capital & Income Fund (FAGIX) at 2.47%. This indicates that FBIOX's price experiences larger fluctuations and is considered to be riskier than FAGIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBIOX | FAGIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.30% | 2.47% | +4.83% |
Volatility (6M)Calculated over the trailing 6-month period | 14.68% | 4.53% | +10.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.91% | 6.95% | +16.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.85% | 6.47% | +18.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.38% | 7.78% | +18.60% |